White label – Pompe disease - ClinicalTrials.eu

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
+4
Gene Therapy Study for Patients with Limb-Girdle Muscular Dystrophy Using GNT0006

Not recruiting

2 1 1 1
Investigated Diseases:
- Muscular dystrophy
Investigated Drugs:
Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

Not recruiting

3 1 1 1
Investigated Diseases:
- Retinopathy of prematurity
Investigated Drugs:
- Aflibercept
+4
Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage III
- Non-small cell lung cancer
Investigated Drugs:
- Brigatinib
- Durvalumab
Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

Not recruiting

2 1 1
Investigated Diseases:
- Bronchiectasis
- Cystic fibrosis
Investigated Drugs:
- Bi 1291583
- Salbutamol Sulfate
Study on the Safety and Effects of Setanaxib for Patients with Alport Syndrome

Not recruiting

2 1
Investigated Diseases:
- Alport’s syndrome
Investigated Drugs:
- Setanaxib
Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- Izokibep
Study on Soticlestat for Children and Adults with Dravet or Lennox-Gastaut Syndrome Previously Treated with Fenfluramine

Not recruiting

3 1 1
Investigated Diseases:
- Lennox-Gastaut syndrome
- Severe myoclonic epilepsy of infancy
Investigated Drugs:
- Soticlestat
Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

Not recruiting

1 1 1
Investigated Diseases:
- B-cell type acute leukaemia
Investigated Drugs:
- Epcoritamab
Study on the Safety and Effectiveness of GEN3017 for Patients with Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies